Objective
To provide shareholders with an attractive level of total return. The focus will be capital growth whilst also providing a growing level of income by investing primarily in a diversified portfolio of UK properties that are leased or intended to be leased to tenants operating in the life science sector.
Launch date
19/11/2021
Domicile
United Kingdom
Fund manager
Stephen Barrow, Simon Farnsworth, Pippa Stacey, Simon Hope, David Lewis, Matthew Barker, Ian Harris
Dividend frequency
Semi-Annually
Wind-up provisions
The Company has entered a Managed Wind-Down.
Continuation vote
7 yearly
Market Cap (m) Total assets (m) Price (last close) NAV Discount / premium (%) Gearing (%) Dividend yield (%) Dividend dates Ongoing charge (%)
135.10 345.10 38.60 67.54 -42.85 44 5.18 Jun, Dec 1.8 (31/12/2024)
Scroll

Note

Dividends

Dividends declared in last 12 months

There have been no dividends in the last 12 months.

Performance (%)

Return type 1 year 3 years 5 years 10 years
Life Science REIT Share price total return 1.6 -41.6 N/A N/A
Property - UK Commercial AIC sector Share price total return 7.2 -3.1 23.7 24.0
Scroll

Share structure

Number of shares
350,000,000

Traded volumes (number of shares)

  Yesterday 1 month 1 year 5 years
Total 312,376 16,014,513 197,505,356 0
Average N/A 727,932 780,654 0
Scroll

Traded values (m)

  Yesterday 1 month 1 year 5 years
Total 0.12 6.08 78.49 0
Average N/A 0.28 0.31 0
Scroll

Trading details

ISIN Ticker Traded currency Stock exchange
GB00BP5X4Q29 LABS GBX London Stock Exchange - MAIN
Chi-x Europe Limited
London Stock Exchange
Scroll

Top holdings

Data as at : 30/06/2025

Investment % of total assets
OTP – Investments 31.2
Rolling Stock Yard 21.9
Cambourne 19.4
7-11 Herbrand Street 18.4
OTP – Developments 7.2
The Merrifield Centre 1.9

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.